Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screeningJohn S. Schardt, Peter M. Tessier|Scientific Reports|2021Cited by 24
ENGINEERED MULTIVALENCY FOR ENHANCED AFFIBODY-BASED HER3 CANCER THERAPYJohn S. Schardt|Digital Repository at the University of Maryland (University of Maryland College Park)|2018Cited by 1